Dr. Farshid Dayyani is Professor of Medicine and a board-certified UCI Health medical oncologist who specializes in the treatment of cancers of the gastrointestinal tract. His clinical interests include colorectal, stomach and esophageal cancers, and anal carcinoma. Dr. Dayyani earned his medical degree at Ludwig Maximilian University of Munich in Germany and completed a residency in internal medicine at Beth Israel Deaconess Medical Center in Boston, a teaching hospital of Harvard Medical School. He also completed a fellowship in medical oncology at the University of Texas MD Anderson Cancer Center in Houston.
Dr. Dayyani’s goal is to bring leading-edge treatments to patients with gastrointestinal cancers through innovative clinical trials and translational research. He is the author or co-author of more than 50 research papers published in leading medical journals.
Research in Lay Terms
My overall goal is to advance clinical and translational research activities in gastrointestinal (GI) cancers at UC Irvine through multidisciplinary collaborations. I have a broad background in basic, translational, and clinical oncology. Given the location of our cancer center in Orange County, CA, we serve a large number of minority patients. We want to offer novel clinical trials to all residents of Orange County.